Once upon a time, gynecologic surgeries almost uniformly meant uterine and abdominal scars, inpatient operations, lengthy hospital stays and significant related post-operative complications and long term morbidities. Then came minimally invasive gynecologic surgery. And the world changed. The benefits of MIGS can’t be overstated, especially with the advent of office hysteroscopy. Women can now have surgical issues addressed in the office, and also look forward to rapid recovery with greatly decreased risk for complications. Remarkably, the technology continues to advance, with finer scopes and instrumentation making even more complex procedures possible in an office setting. Yet a few barriers remain to making office hysteroscopy, when clinically appropriate, available to all. That is where the Hysteroscopy Newsletter comes in.
The Hysteroscopy Newsletter is a collection of open access, educational entries, dedicated to ‘all things hysteroscopy’. Basic education, suggestions for difficult cases, technology overviews and interviews with some of the top surgeons practicing today. The goal? Using education to advance the cause of office hysteroscopy so that every woman, wherever she may be, has access to this surgical approach when clinically indicated.
As Dr. Nash Moawad states so well
The field of hysteroscopic surgery has seen many advances over the years, from improved optics, the flexible hysteroscope, the resectoscope, hysteroscopic morcellators and most recently, the 5-mm “mini”-resectoscope. The art of hysteroscopy never stops to amaze me. The ability to perform a complex surgical procedure inside of the uterine cavity, without incisions, in the outpatient setting is revolutionary.
The Hysteroscopy Newsletter is all about the ObGyn community working together to drive this innovation revolution forward.
Imagine a group of international professional colleagues, who are highly skilled MIGS surgeons with a collective passion for office hysteroscopy. Combine that with deep experience in medical education and patient care. The editors of the Hysteroscopy Newsletter exemplify what international collaboration for the sake of women’s health looks like at its best.
The ObG Project® will be posting selected entries, designed for your smartphone or any computer, from the Hysteroscopy Newsletter on topics that are relevant to the ever growing community of ObGyns who are expanding their use of office hysteroscopy.
You can find the entire set of newsletters (in multiple languages) at the Hysteroscopy Newsletter Website.
Set aside time in your calendar now for the Global Congress on Hysteroscopy Barcelona, 30 April-3 May, 2019. With parallel tracks for everyone – beginners, advanced and expert. The Board of the Global Congress on Hysteroscopy includes representatives of ALL international endoscopy societies (ESGE, AAGL, ISGE, APAGE and MESGE) together with a group of relevant and independent hysteroscopists. It’s all about learning with each other, from each other.
The ObG Project offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet. When you click on these links you will leave The ObG Project’s website and will be redirected to another site. These sites are not under the control of The ObG Project.
The ObG Project is not responsible for the software or content of linked third party websites.
Also, please be aware that the security and privacy policies on these sites may be different than The ObG Project’s policies, so please read third party privacy and security policies closely.
If you have any questions or concerns about the products and services offered on linked third party websites, please contact the third party directly.
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.